Rahul Valsaraj, Awadhesh Kumar Singh, Kalyan Kumar Gangopadhyay, Biswajit Ghoshdastidar, Ghanshyam Goyal, Masood Batin, Dibyendu Mukherjee, Upal Sengupta, Sanjay Chatterjee, Nilanjan Sengupta
Journal: Diabetes & metabolic syndrome 2020;14(2):93-100
PMID: 31991299
AIM
The definition and management of asymptomatic hyperuricemia has been an area of controversy for many decades. Debate persists regarding the benefit of treating all cases of asymptomatic hyperuricemia and hence, unsurprisingly there are no clear clinical practice guidelines from our country.
PARTICIPANTS
Ten members consisting of eminent physicians, endocrinologists, nephrologist and a rheumatologist were selected by the Integrated Diabetes & Endocrine Academy (IDEA) for a closed meeting with the aim to come to a consensus.
EVIDENCE
A literature search was performed using PubMed and Cochrane library following which published articles in indexed peer review journals were selected.
CONSENSUS PROCESS
Each participant voiced their opinion after reviewing the available data and a consensus was reached after three meetings by voting.
CONCLUSION
Recommendations were made on important areas such as definition, investigation and management of asymptomatic hyperuricemia.
Copyright © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.